YFY Biotech Management Company
About Us
Company Profile
Management Team
Capital Funds
Portfolio
News
Contact Us
繁體
English
News
SEARCH
Year
2024
2023
2022
2021
2020
2019
2018
2017
Mar 5, 2018
Lumosa's LT1001 Approved in Taiwan
READ MORE
Dec 26, 2017
TLC Achieves Full Enrollment in TLC599 Phase II Osteoarthritis Pain Management Clinical Trial
READ MORE
Dec 7, 2017
TaiGen's Taigexyn Received Reimbursement Price from Taiwan’s National Health Insurance Administration
READ MORE
Nov 27, 2017
R-Pharm Has Completed Enrollment for the Phase III Clinical Trial of Taigexyn in Community Acquired Pneumonia in Russia
READ MORE
Nov 6, 2017
TaiGen's Intravenous Taigexyn Successfully Completed Phase 3 Clinical Trial for Community Acquired Pneumonia in Taiwan
READ MORE
Aug 28, 2017
Lumosa Partners with Camargo in Dev
READ MORE
Aug 19, 2017
Mid-Cycle Review Meeting for TMB-355 Biologics License Application
READ MORE
Aug 8, 2017
TBG ExProbe™ Real Time PCR Based Typing Kit receives Taiwan FDA approval and CE Mark, immediately opens markets
READ MORE
prev
1
2
3
4
5
next
YFY Biotech Management Company